Sonoma Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Sonoma Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -63.7 %, a 31.5% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Return On Equity for 2023 was -67.8 %, a 18.3% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Return On Equity for 2022 was -57.3 %, a 12.4% decline from 2021.
  • Sonoma Pharmaceuticals, Inc. annual Return On Equity for 2021 was -51 %, a 24.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -67.8 -10.5 -18.3% Apr 1, 2023 Mar 31, 2024
2022 -57.3 -6.34 -12.4% Apr 1, 2022 Mar 31, 2023
2021 -51 -10.1 -24.6% Apr 1, 2021 Mar 31, 2022
2020 -40.9 -11.2 -37.7% Apr 1, 2020 Mar 31, 2021
2019 -29.7 +43.6 +59.5% Apr 1, 2019 Mar 31, 2020
2018 -73.3 +25.3 +25.7% Apr 1, 2018 Mar 31, 2019
2017 -98.7 -189 -209% Apr 1, 2017 Mar 31, 2018
2016 90.2 +177 Apr 1, 2016 Mar 31, 2017
2015 -87.1 +80.1 +47.9% Apr 1, 2015 Mar 31, 2016
2014 -167 -379 -179% Apr 1, 2014 Mar 31, 2015
2013 212 -4.57K -95.6% Apr 1, 2013 Mar 31, 2014
2012 4.79K Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.